Table 3.
Steatosis grading of non-tumor liver parenchyma from both Peruvian patients with hepatocellular carcinoma and comparative individuals.
| Steatosis grade | Contingency in Patient Group (n) | Percentage in Patient Group (%) | Contingency in Comparative Group (n) | Percentage in Comparative Group (%) |
|---|---|---|---|---|
| Grade 0 | 37 | 74 | 52 | 69.3 |
| Grade 1 | 11 | 22 | 13 | 17.3 |
| Grade 2 | 1 | 2 | 8 | 10.7 |
| Grade 3 | 1 | 2 | 2 | 2.7 |
| Total | 50 | 100 | 75 | 100 |
Hepatic steatosis was graded using the system established by the Non-alcoholic Steatohepatitis Clinical Research Network52. Grade 0, less than 5% of parenchymal involvement by steatosis; Grade 1, from 5% to 33% of parenchymal involvement by steatosis; Grade 2, from 33% to 66% of parenchymal involvement by steatosis; Grade 3, more than 66% of parenchymal involvement by steatosis.